Douglas M. Fambrough, III
2014
In 2014, Douglas M. Fambrough, III earned a total compensation of $5.3M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 211% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,264 |
|---|---|
| Option Awards | $4,654,689 |
| Salary | $430,000 |
| Other | $10,490 |
| Total | $5,288,443 |
Fambrough received $4.7M in option awards, accounting for 88% of the total pay in 2014.
Fambrough also received $193.3K in non-equity incentive plan, $430K in salary and $10.5K in other compensation.
Rankings
In 2014, Douglas M. Fambrough, III's compensation ranked 1,447th out of 13,032 executives tracked by ExecPay. In other words, Fambrough earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,447 out of 13,032 | 89th |
Division Manufacturing | 522 out of 4,966 | 90th |
Major group Chemicals And Allied Products | 162 out of 1,686 | 90th |
Industry group Drugs | 127 out of 1,365 | 91st |
Industry Pharmaceutical Preparations | 112 out of 1,043 | 89th |
Source: SEC filing on April 29, 2016.
Fambrough's colleagues
We found two more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2014.